Related Experiment Videos
Cost implications of lipid-lowering treatments
1School of Postgraduate Medicine, University of Bath, Royal United Hospital, England.
Insights
Coronary heart disease (CHD) management requires evaluating cost-effectiveness. Comparing treatment costs for existing disease with prevention programs is essential for healthcare cost control.
Area of Science:
- Cardiovascular Medicine
- Health Economics
Background:
- Coronary heart disease (CHD) is a leading cause of illness and death globally.
- CHD significantly impacts healthcare expenditures worldwide.
Purpose of the Study:
- To assess the cost-effectiveness of various coronary heart disease management strategies.
- To compare the economic impact of treating existing CHD versus implementing prevention programs.
Main Methods:
- Analysis of treatment costs for different CHD procedures.
- Comparative economic evaluation of interventions and preventive measures.
Main Results:
- Treatment costs for established CHD procedures vary.
- Prevention programs offer a potential alternative for cost management.
Conclusions:
- Cost-effectiveness analysis is crucial for optimizing CHD management.
- Balancing treatment and prevention costs is key to addressing rising healthcare expenses.
Abstract:
Coronary heart disease (CHD) is the major cause of morbidity and mortality in the Western world, and contributes substantially to global healthcare costs. As pressure rises to certain health costs, it is essential to consider the cost-effectiveness of different management strategies. In terms of CHD, treatment costs for different procedures for existing disease can be considered, and can also be compared with the costs of prevention programmes.